Next Article in Journal
Activation and Disproportionation of Zr2Fe Alloy as Hydrogen Storage Material
Previous Article in Journal
Antiviral Activities of Silymarin and Derivatives
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 24
Issue 8
10.3390/molecules24081553
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synthesis and In Vitro Antibacterial Activity of Quaternized 10-Methoxycanthin-6-one Derivatives

by
Na Li
1,
Dan Liu
2,
Jiang-Kun Dai
2,
Jin-Yi Wang
1,2,* and
Jun-Ru Wang
2,*
1
College of Veterinary Medicine, Northwest A&F University, Yangling 712100, Shaanxi, China
2
College of Chemistry and Pharmacy, Northwest A&F University, Yangling 712100, Shaanxi, China
*
Authors to whom correspondence should be addressed.
Molecules 2019, 24(8), 1553; https://doi.org/10.3390/molecules24081553
Submission received: 27 March 2019 / Revised: 16 April 2019 / Accepted: 16 April 2019 / Published: 19 April 2019
(This article belongs to the Section Medicinal Chemistry)
Browse Figures
Review Reports Versions Notes

Abstract

:
Background: Based on our previous work, we found that 10-methoxycanthin-6-one displayed potential antibacterial activity and quaternization was an available method for increasing the antibacterial activity. Here, we explored the antibacterial activity of quaternized 10-methoxy canthin-6-one derivatives. Methods and Results: Twenty-two new 3-N-benzylated 10-methoxy canthin-6-ones were designed and synthesized through quaternization reaction. The in vitro antibacterial activity against three bacteria was evaluated by the double dilution method. Moreover, the structure–activity relationships (SARs) were carefully summarized in order to guide the development of antibacterial canthin-6-one agents. Two highly active compounds (6p and 6t) displayed 8-fold superiority (MIC = 3.91 µg/mL) against agricultural pathogenic bacteria R. solanacearum and P. syringae compared to agrochemical streptomycin sulfate, and showed potential activity against B. cereus. Moreover, these two compounds exhibited good “drug-like” properties, low cytotoxicity, and no inhibition on seed germination. Conclusions: This work provides two new effective quaternized canthin-6-one derivatives as candidate bactericide, promoting the development of natural-sourced bactericides and preservatives.

Graphical Abstract

1. Introduction

Healthcare systems, farming, and the food production industry are the main sectors driving antibiotic consumption [1]. To maintain agricultural production and food safety, there are many circumstances where antibiotics are required in the farming and food industry [2,3]. Bacillus cereus is pathogenic and is the common cause of spoilage of milk, cream and cooked rice. When people eat B. cereus contaminated food, they will suffer from food poisoning with these symptoms’ nausea, vomiting and diarrhea [4]. The synthetic preservatives could fully retain food nutrients. However, consumers are increasingly concerned about the safety of the pure synthetic chemicals [5]. Therefore, the development of effective natural-sourced antibacterial agents for food preservation and food safety is in great demand [6]. Ralstonia solanacearum and Pseudomonas syringae, plant pathogens, could infect the plant tissues during the whole plant growth cycle [7]. Although chemical pesticides work quickly, they cause serious environmental pollution, human and animal poisoning, and pesticide residues [8]. Recently, structural modifications of natural products for the discovery of agrochemical candidates have received much attention because of their low toxicity, low residue and environmental friendliness [8,9]. Canthin-6-one 1, mainly from the Rutaceae and Simaroubaceae families, are a subclass of the tryptophan-derived β-carboline alkaloids [10,11]. In our previous work, we found that quaternized modification could significantly improve the antibacterial activity (Figure 1) [12,13]. For example, the antibacterial activity of compounds 2 and 4 against B. cereus enhanced 2-fold and 8-fold, respectively. Interestingly, 10-methoxycanthin-6-one 5, per se has good antibacterial activity [14,15]. With the aim of finding more promising antibacterial canthin-6-one analogues, we report here a simple idea and design to generate the bioactive compounds by quaternization reaction of 10-methoxycanthin-6-one 5.

2. Results and Discussion

2.1. Chemistry

The synthetic route of target compounds 6a–6v was outlined in Scheme 1. The Nb-benzyl-5-methoxytryptamine 8 was prepared through Borch Reduction with 5-methoxytryptamine 7 as the starting material (98% yield). Then, Nb-benzylhexahydro-10-methoxycanthin-6-one 9 was obtained by the key Pictet–Spengler reaction (83% yield). The debenzylated compound 10 (hexahydro-10-methoxycanthin-6-one) was sequentially obtained by catalytic hydrogen transfer reaction (75% yield). Finally, the natural product 10-methoxycanthin-6-one 5 was prepared by oxidation reaction (90% yield) [15]. With this compound 5 in hand, attention was focused on modifying the 3-N position. A benzyl group in this position significantly increased the activity (Figure 1). Thus, we synthesized a series of quaternized 10-methoxycanthin-6-one derivatives 6a–6v (42–72% yields) with diverse substituted benzyl group which varied in electron-inducing ability and substitution position.
The purity of the compounds (>99%) has been provided using high performance liquid chromatography (HPLC), which could be found in the Supporting Information. All the structures of the target compounds (5 and 6a–6v) were confirmed by NMR and high resolution MS (HRMS) spectra. In the NMR spectra of compound 6a, the signal of the methylene group was detected around δ = 6.39 ppm and δ = 56.6 ppm, respectively, which indicated that the quaternized 10-methoxycanthin-6-one derivatives were successfully synthesized. Moreover, the charactermatic signals of the methyl group were easily detected around δ = 3.96 ppm (1H NMR) and δ = 54.4 ppm (13C NMR). In addition, the signal of [M − Br]+ could be found at 359.1182 Da in HRMS spectra of compound 6a (error = 2.2 ppm), which confirmed to the theoretical value 359.1190 Da within the allowable error range (error < 5 ppm).

2.2. Antibacterial Activity

The antibacterial activity in vitro of compounds 5 and 6a–6v were evaluated against bacteria (B. cereus, R. solanacearum and P. syringae) using the double dilution method giving the minimum inhibitory concentration values (MICs) [16]. The concentration gradient was set according to our previous work [12,15]. Broad spectrum antibiotic fosfomycin sodium and ampicillin sodium, and agrochemical bactericide streptomycin sulfate were used as the positive controls [17,18]. The antibacterial results (Table 1) revealed that most of the quaternized 10-methoxycanthin-6-one derivatives displayed good in vitro biological activity against R. solanacearum and P. syringae compared with agrochemical streptomycin sulfate. Eight compounds (6e, 6f, 6i, 6k, 6l, 6m, 6p and 6t) displayed 4-fold superiority (MIC = 3.91 µg/mL) against R. solanacearum than lead compound 5 and 8-fold superiority than streptomycin sulfate. Five compounds (6f, 6h, 6i, 6p and 6t) displayed 2-fold superiority (MIC = 3.91 µg/mL) against P. syringae compared to lead compound 5 and 8-fold superiority than streptomycin sulfate. Unfortunately, quaternized modification did not improve the activity for B. cereus. It is worth mentioning that four compounds (6p, 6q, 6r and 6t) still have potential antibacterial activity against B. cereus compared with natural canthin-6-one 1. Overall, compounds 6p and 6t were considered to be the most highly active derivatives against these three bacteria.

2.3. Structure–Activity Relationships

Based on the antibacterial activity data, the structure–activity relationships were carefully investigated for R. solanacearum and P. syringae. Halogen anion did not affect the activity. For example, the antibacterial activity of compounds 6u and 6v are equal. The substituted benzyl groups are favorable for most of the quaternized derivatives. The detailed SARs of a diverse substituted benzyl group which varied in electron-inducing ability and substitution position were summarized in Table 2. In terms of halogen atom substitution, fluorine substituted benzyl groups are disadvantageous for improving the activity. Chlorine and iodine substituents may be better. For example, compound 6t with meta-iodine atom substituent displayed 4-fold superiority against P. syringae than compound 6c which was replaced by a fluorine atom at meta-position. In most instances, large sterically hindered groups such as methyl and trifluoromethyl are beneficial for activity enhancement. For example, compound 6k displayed 8-fold superiority (MIC = 3.91 µg/mL) against R. solanacearum compared to positive control streptomycin sulfate, which was replaced by the trifluoromethyl group at ortho-position. However, cyano and methoxy groups were exceptional and complex, which need further study. Multiple substitutions showed different activity trends. Compound 6p exhibited excellent antibacterial activity compared with agrochemical streptomycin sulfate. Interestingly, multiple fluorine substituted benzyl groups are still harmful, such as compounds 6n and 6o.

2.4. Molecular Physicochemical Properties

In 1997, Lipinski et al. published what is widely regarded as the key paper defining physicochemical and structural properties profiles for the optimal oral availability of drugs [19]. In 2003, Clarke and Delaney reported that most herbicides and fungicides also adhere to the Lipinski rule [20]. The molecular properties of compounds 5, 6p and 6t are shown in Table 3. For all the preferred compounds, the logP values were lower than 5, the nON values were lower than 10, the nONNH values were lower than 10, the MW values were lower than 500 and the nrotb values were lower than 5. Their physicochemical data conform to the Lipinski rule which demonstrate they may have good “drug-like” properties. Further more, the topological polar surface area (TPSA), a parameter, defined as the surface sum over all polar atoms and used extensively in medicinal chemistry to predict absorption and optimize a compound’s membrane permeability, was also calculated. It is suggested that compounds with a TPSA greater than 140 Å2 tend to be poor at permeating cell membranes [21]. Based on the predicted data mentioned above, the calculated TPSA values for these three compounds would indicate a possible good bioavailability. Interestingly, the TPSA values of 6p and 6t are lower than 5, which indicate that the modified molecules may pass through the bacteria cell membrane more easily.

2.5. In Vitro Toxicity of the Highly Active Derivatives 6p and 6t

Many natural and synthetic agents with the ability to interact with DNA often have a relatively low therapeutic index, most likely due to the unspecific manner of these agents in causing DNA damage both in lesions and in highly proliferative normal tissues [22]. Similarly, the frequency of utilization of β-carbolines is greatly reduced because of their cytotoxic activity toward mammalian cells (low selectivity) [14,22]. We determined the cytotoxic effects of the highly bioactive quaternized derivatives 6p and 6t on BHK-21 cells (Baby hamster Syrian kidney cells). As shown in Table 4, the cell viabilities of all the tested compounds were more than 96% on BHK-21 cells even up to concentrations of 15.62 μg/mL (2-fold or 4-fold MIC values). The results suggest that these molecules are of low toxicity against mammalian cells when they act as antibacterial agents.

2.6. Germination Rate Evaluation of the Highly Active Derivatives 6p and 6t

The disease caused by R. solanacearum could be controlled before planting [23]. Thus, the effect of bactericides on seed germination rate is more important. Compounds 6p and 6t were evaluated for allelopathic activity against dicotyledon turnip (Raphanus sativus) and monocotyledon wheat (Triticum aestivum L.) seeds by determining the germination rates with respect to the positive control, glyphosate, a broad-spectrum systemic herbicide [14]. As shown in Table 5, compounds 6p and 6t showed no inhibition on germination rates under an effective antibacterial dose (3.91 μg/mL), which indicated that these molecules would not inhibit plant growth when it acts as bactericides.

3. Materials and Methods

3.1. General Details

All the reagents and solvents were obtained locally or purified according to standard methods. Melting points were determined using a digital melting-point apparatus and were uncorrected. 1H NMR (500 MHz) and 13C NMR (125 MHz) spectra were recorded using a Bruker Avance III 500 MHz instrument (Bruker, Madison, WI, USA) with Tetramethylsilane(TMS) as the internal standard and dimethylsulfoxide (DMSO-d6) as the solvent. High-resolution mass spectroscopy (HRMS) was undertaken using an AB SCIEX Triple TOF 5600+ spectrometer (Carlsbad, CA, USA). The purity of all compounds was detected by HPLC (Shimadzu LC-20A, Tokyo, Japan) with the system equipped with a C18 trap column (4.6 mm i.d. × 250 mm, 5 μm). The mobile phase was an aqueous methanol solution (50%) with the flow rate of 1.0 mL/min. The silica gel and GF254 silica gel of analytical thin-layer chromatography (TLC) were produced by the Qingdao Haiyang Chemical Co., Ltd. (Qingdao, China).

3.2. Synthesis of Target Compounds 6a−6v

The 10-methoxy canthin-6-one 5 could be easily obtained according to our previous work [15]. Compound 5 was dissolved in CH3CN (50 mL) and the diverse substituted benzyl bromide or chloride (5 eq.) was added. The solution was then stirred at 80 °C until the reaction is completed. The reaction solution was concentrated under reduced pressure, and purified by flash column chromatography using chloroform/methanol (30:1, v/v) as the eluent.
3-(2-Fluorobenzyl)-10-methoxy-6-oxo-6H-indolo[3,2,1-de][1,5]naphthyridin-3-ium bromide6a: yield 60%; yellow-green solid powder; m.p. 224.2–224.7 °C; 1H NMR (500 MHz, DMSO-d6) δ 9.29 (d, J = 5.0 Hz, 1H), 8.96 (d, J = 5.0 Hz, 1H), 8.59 (d, J = 10.0 Hz, 1H), 8.43 (d, J = 10.0 Hz, 1H), 8.25 (d, J = 5.0 Hz, 1H), 7.58–7.50 (m, 1H), 7.51–7.46 (m, 1H), 7.40 (d, J = 10.0 Hz, 1H), 7.36–7.32 (m, 2H), 7.24 (d, J = 10.0 Hz, 1H), 6.39 (s, 2H), 3.96 (s, 3H); 13C NMR (125 MHz, DMSO-d6) δ 158.7, 157.5, 142.6, 136.7, 136.3, 134.6, 134.5, 132.0, 131.9, 130.6, 130.2, 130.0, 125.7, 124.1, 122.8, 120.1, 117.9, 116.5, 116.3, 109.3, 56.6, 54.4. HRMS (ESI) m/z calcd for C22H16BrFN2O2 [M − Br]+ 359.1190, found 359.1182.
3-(4-Fluorobenzyl)-10-methoxy-6-oxo-6H-indolo[3,2,1-de][1,5]naphthyridin-3-ium bromide6b: yield 61%; yellow-green solid powder; m.p. 233.2–235.0 °C; 1H NMR (500 MHz, DMSO-d6) δ 9.44 (d, J = 5.0 Hz, 1H), 9.03 (d, J = 5.0 Hz, 1H), 8.67 (d, J = 10.0 Hz, 1H), 8.43 (d, J = 5.0 Hz, 1H), 8.31 (s, 1H), 7.58−7.54 (m, 3H), 7.40 (d, J = 10.0 Hz, 1H), 7.32−7.28 (m, 2H), 6.35 (s, 2H), 3.98 (s, 3H); 13C NMR (125 MHz, DMSO-d6) δ 158.6, 157.5, 142.4, 136.5, 136.2, 134.6, 131.3, 130.6, 130.5, 130.3, 130.1, 124.1, 122.6, 120.3, 117.8, 116.5, 116.4, 109.4, 58.5, 56.6. HRMS (ESI) m/z calcd for C22H16BrFN2O2 [M − Br]+ 359.1190, found 359.1180.
3-(3-Fluorobenzyl)-10-methoxy-6-oxo-6H-indolo[3,2,1-de][1,5]naphthyridin-3-ium bromide6c: yield 65%; brick yellow solid powder; m.p. 241.6–241.9 °C; 1H NMR (500 MHz, DMSO-d6) δ 9.40 (d, J = 5.0 Hz, 1H), 9.00 (d, J = 5.0 Hz, 1H), 8.64 (d, J = 10.0 Hz, 1H), 8.40 (d, J = 10.0 Hz, 1H), 8.27 (d, J = 2.5 Hz, 1H), 7.55–7.52 (m, 3H), 7.51 (d, J = 10.0 Hz, 1H), 7.39–7.25 (m, 2H), 6.31 (s, 2H), 3.95 (s, 3H); 13C NMR (125 MHz, DMSO-d6) δ 163.7, 161.7, 158.6, 157.5, 142.4, 136.5, 136.2, 134.6, 134.6, 130.6, 130.5, 130.3, 130.1, 124.1, 122.6, 120.2, 117.8, 116.5, 116.4, 109.3, 58.5, 56.6. HRMS (ESI) m/z calcd for C22H16BrFN2O2 [M − Br]+ 359.1190, found 359.1184.
3-(3-Cyanobenzyl)-10-methoxy-6-oxo-6H-indolo[3,2,1-de][1,5]naphthyridin-3-ium chloride6d: yield 45%; brick red solid powder; m.p. 225.8–227.7 °C; 1H NMR (500 MHz, DMSO-d6) δ 9.38 (d, J = 10.0 Hz, 1H), 9.02 (d, J = 5.0 Hz, 1H), 8.53 (d, J = 10.0 Hz, 1H), 8.46 (d, J = 10.0 Hz, 1H), 8.30 (s, 1H), 7.94 (d, J = 10.0 Hz, 2H), 7.60 (d, J = 10 Hz, 1H), 7.55 (d, J = 5.0 Hz, 2H), 7.39 (d, J = 10.0 Hz, 1H), 6.45 (s, 2H), 3.99 (s, 3H); 13C NMR (125 MHz, DMSO-d6) δ 158.6, 157.5, 142.5, 136.5, 136.2, 135.1, 134.6, 134.5, 130.3, 130.1, 129.6, 129.4, 127.9, 124.1, 122.6, 120.2, 117.8, 112.6, 109.3, 59.3, 56.6. HRMS (ESI) m/z calcd for C23H16ClN3O2 [M − Cl]+ 366.1237, found 366.1236.
3-(2-Chlorobenzyl)-10-methoxy-6-oxo-6H-indolo[3,2,1-de][1,5]naphthyridin-3-ium chloride6e: yield 44%; yellow solid powder; m.p. 231.2–232.9 °C; 1H NMR (500 MHz, DMSO-d6) δ 9.44 (s, 1H), 9.00 (s, 1H), 8.62 (d, J =10.0 Hz, 1H), 8.40 (d, J = 10.0 Hz, 1H), 8.26 (s, 1H), 7.54 (d, J = 5.0 Hz, 1H), 7.42–7.32 (m, 5H), 6.36 (s, 2H), 3.95 (s, 3H); 13C NMR (125 MHz, DMSO-d6) δ 158.7, 157.5, 142.6, 136.6, 136.3, 136.2, 135.1, 135.1, 134.6, 130.3, 130.1, 130.1, 129.5, 129.4, 129.3, 127.9, 122.6, 120.2, 117.8, 109.5, 59.3, 56.6. HRMS (ESI) m/z calcd for C22H16Cl2N2O2 [M − Cl]+ 375.0894, found 375.0900.
3-(3-Chlorobenzyl)-10-methoxy-6-oxo-6H-indolo[3,2,1-de][1,5]naphthyridin-3-ium chloride6f: yield 47%; brick yellow solid powder; m.p. 229.5–231.2 °C; 1H NMR (500 MHz, DMSO-d6) δ 9.11 (d, J = 5.0 Hz, 1H), 8.75 (d, J = 5.0 Hz, 1H), 8.38 (d, J = 10.0 Hz, 1H), 8.30 (d, J = 10.0 Hz, 1H), 8.03 (s, 1H), 7.61–7.32 (m, 5H), 7.23 (d, J = 10.0 Hz, 1H), 6.18 (s, 2H), 3.90 (s, 3H); 13C NMR (125 MHz, DMSO-d6) δ 158.6, 157.5, 142.5, 136.6, 136.2, 134.7, 134.6, 134.1, 134.0, 132.4, 130.3, 130.2, 130.0, 130.0, 129.5, 124.1, 122.7, 120.2, 117.9, 109.3, 58.5, 56.6. HRMS (ESI) m/z calcd for C22H16Cl2N2O2 [M − Cl]+ 375.0894, found 375.0891.
10-Methoxy-3-(2-methylbenzyl)-6-oxo-6H-indolo[3,2,1-de][1,5]naphthyridin-3-ium bromide6g: yield 68%; brick yellow solid powder; m.p. > 280 °C; 1H NMR (500 MHz, DMSO-d6) δ 9.18 (d, J = 10.0 Hz, 1H), 9.00 (d, J = 5.0 Hz, 1H), 8.44 (d, J = 10.0 Hz, 2H), 8.31 (d, J = 2.5 Hz, 1H), 7.58−7.56 (m, 1H), 7.37–7.34 (m, 2H), 7.28 (t, J = 7.5 Hz, 1H), 7.09 (t, J = 7.5 Hz, 1H), 6.55 (d, J = 10.0 Hz, 1H), 6.33 (s, 2H), 3.96 (s, 3H), 2.43 (s, 3H); 13C NMR (125 MHz, DMSO-d6) δ 158.6, 157.7, 142.4, 136.7, 136.3, 136.0, 134.7, 134.5, 133.8, 130.9, 130.8, 130.3, 128.9, 127.0, 126.1, 124.2, 122.7, 120.3, 117.8, 109.4, 57.8, 56.6, 19.3. HRMS (ESI) m/z calcd for C23H19BrN2O2 [M − Br]+ 355.1441, found 355.1439.
10-Methoxy-3-(4-methylbenzyl)-6-oxo-6H-indolo[3,2,1-de][1,5]naphthyridin-3-ium bromide6h: yield 71%; yellow solid powder; m.p. 228.6–228.9 °C; 1H NMR (500 MHz, DMSO-d6) δ 9.40 (d, J = 5.0 Hz, 1H), 9.00 (d, J = 2.5 Hz, 1H), 8.63 (d, J = 10.0 Hz, 1H), 8.42 (d, J = 10.0 Hz, 1H), 8.27 (d, J = 5.0 Hz, 1H), 7.56 (d, J = 5.0 Hz, 1H), 7.39−7.34 (m, 3H), 7.26−7.25 (m, 2H), 6.29 (s, 2H), 3.97 (s, 3H), 2.31 (s, 3H); 13C NMR (125 MHz, DMSO-d6) δ 158.6, 157.5, 142.4, 139.0, 136.4, 136.2, 136.0, 134.6, 134.5, 132.1, 130.2, 130.1, 128.0, 124.1, 122.6, 120.2, 117.8, 109.3, 59.2, 56.6, 21.1. HRMS (ESI) m/z calcd for C23H19BrN2O2 [M − Br]+ 355.1441, found 355.1436.
10-Methoxy-3-(3-methylbenzyl)-6-oxo-6H-indolo[3,2,1-de][1,5]naphthyridin-3-ium bromide6i: yield 70%; yellow solid powder; m.p. 222.4–222.7 °C, 1H NMR (500 MHz, DMSO-d6) δ 9.38 (d, J = 5.0 Hz, 1H), 8.98 (d, J = 10.0 Hz, 1H), 8.57 (d, J = 10.0 Hz, 1H), 8.35 (d, J = 10.0 Hz, 1H), 8.24 (d, J = 5.0 Hz, 1H), 7.50–7.48 (m, 1H), 7.34 (d, J = 10.0 Hz, 1H), 7.28 (t, J = 10.0 Hz, 1H), 7.19–7.17 (m, 3H), 6.27 (s, 2H), 3.92 (s, 3H), 2.25 (s, 3H); 13C NMR (125 MHz, DMSO-d6) δ 158.6, 157.5, 142.5, 139.0, 136.5, 136.2, 135.1, 134.6, 134.5, 130.3, 130.1, 130.0, 129.5, 128.3, 125.0, 124.1, 122.6, 120.2, 117.8, 109.3, 59.2, 56.6, 21.4. HRMS (ESI) m/z calcd for C23H19BrN2O2 [M − Br]+ 355.1441, found 355.1449.
10-Methoxy-3-(3-methoxybenzyl)-6-oxo-6H-indolo[3,2,1-de][1,5]naphthyridin-3-ium chloride6j: yield 43%; brick yellow solid powder; m.p. 225.3–226.0 °C; 1H NMR (500 MHz, CD3OD) δ 9.11 (d, J = 5.0 Hz, 1H), 8.74 (d, J = 10.0 Hz, 1H), 8.55 (d, J = 10.0 Hz, 1H), 8.30 (d, J = 10.0 Hz, 1H), 7.95 (d, J = 2.5 Hz, 1H), 7.48 (d, J = 10.0 Hz, 2H), 7.37−7.35 (m, 1H), 7.30 (d, J = 10.0 Hz, 1H), 7.06 (d, J = 10.0 Hz, 2H), 6.20 (s, 2H), 3.98 (s, 3H), 3.83 (s, 3H); 13C NMR (125 MHz, CD3OD) δ 160.5, 158.9, 157.5, 141.3, 137.0, 136.1, 134.0, 134.0, 132.0, 129.6, 129.6, 129.0, 125.3, 123.6, 122.4, 121.6, 119.2, 117.6, 114.8, 107.8, 59.6, 55.6, 54.9. HRMS (ESI) m/z calcd for C23H19ClN2O3 [M − Cl]+ 371.1390, found 371.1383.
10-Methoxy-6-oxo-3-(2-(trifluoromethyl)benzyl)-6H-indolo[3,2,1-de][1,5]naphthyridin-3-ium bromide6k: yield 70%; yellow solid powder; m.p. 243.6–244.1 °C; 1H NMR (500 MHz, DMSO-d6) δ 9.22 (d, J = 5.0 Hz, 1H), 9.00 (d, J = 10.0 Hz, 1H), 8.47 (d, J = 10.0 Hz, 1H), 8.30−8.28 (m, 2H), 7.96 (d, J = 7.5 Hz, 1H), 7.69–7.55 (m, 3H), 7.36 (d, J = 10.0 Hz, 1H), 6.82 (d, J = 5.0 Hz, 1H), 6.51 (s, 2H), 3.98 (s, 3H); 13C NMR (125 MHz, DMSO-d6) δ 158.7, 157.6, 143.0, 137.1, 136.4, 135.7, 134.8, 134.7, 134.0, 132.8, 130.8, 130.0, 129.8, 128.2, 127.3, 126.3, 124.1, 122.9, 120.3, 117.9, 109.4, 56.6, 56.5. HRMS (ESI) m/z calcd for C23H16BrF3N2O2 [M − Br]+ 409.1158, found 409.1157.
10-Methoxy-6-oxo-3-(4-(trifluoromethyl)benzyl)-6H-indolo[3,2,1-de][1,5]naphthyridin-3-ium bromide6l: yield 68%; yellow solid powder; m.p. 238.5–238.9 °C; 1H NMR (500 MHz, DMSO-d6) δ 9.43 (d, J = 10.0 Hz, 1H), 9.01 (d, J = 5.0 Hz, 1H), 8.63 (d, J = 10.0 Hz, 1H), 8.41 (d, J = 10.0 Hz, 1H), 8.28 (s, 1H), 7.92 (s, 1H), 7.77 (d, J = 5.0 Hz, 1H), 7.64 (s, 2H), 7.54 (d, J = 10.0 Hz, 1H), 7.39 (d, J = 10.0 Hz, 1H), 6.43 (s, 2H), 3.95 (s, 3H); 13C NMR (125 MHz, DMSO-d6) δ 158.6, 157.6, 142.7, 139.7, 136.7, 136.2, 134.8, 134.7, 130.5, 130.0, 128.6, 126.4, 125.5, 124.1, 123.3, 122.7, 120.3, 117.9, 109.3, 58.6, 56.6. HRMS (ESI) m/z calcd for C23H16BrF3N2O2 [M − Br]+ 409.1158, found 409.1162.
10-Methoxy-6-oxo-3-(3-(trifluoromethyl)benzyl)-6H-indolo[3,2,1-de][1,5]naphthyridin-3-ium bromide6m: yield 72%; brick red solid powder; m.p. 223.3–223.7 °C; 1H NMR (500 MHz, DMSO-d6) δ 9.38 (d, J = 5.0 Hz, 1H), 8.99 (d, J = 5.0 Hz, 1H), 8.53 (d, J = 10.0 Hz, 1H), 8.40 (d, J = 5.0 Hz, 1H), 8.26 (d, J = 2.5 Hz, 1H), 7.77 (d, J = 5.0 Hz, 2H), 7.57–7.54 (m, 3H), 7.35 (d, J = 10.0 Hz, 1H), 6.42 (s, 2H), 3.93 (s, 3H); 13C NMR (125 MHz, DMSO-d6) δ 158.6, 157.6, 142.6, 136.6, 136.3, 136.2, 134.8, 134.7, 132.0, 130.7, 130.5, 130.2, 130.0, 126.1, 125.4, 125.0, 124.1, 122.7, 120.3, 117.8, 109.4, 58.5, 56.6. HRMS (ESI) m/z calcd for C23H16BrF3N2O2 [M − Br]+ 409.1158, found 409.1165.
3-(2,5-Difluorobenzyl)-10-methoxy-6-oxo-6H-indolo[3,2,1-de][1,5]naphthyridin-3-ium bromide6n: yield 61%; yellow solid powder; m.p. 245.1–245.8 °C; 1H NMR (500 MHz, DMSO-d6) δ 9.32 (d, J = 5.0 Hz, 1H), 8.99 (d, J = 10.0 Hz, 1H), 8.58 (d, J = 10.0 Hz, 1H), 8.43 (d, J = 5.0 Hz, 1H), 8.29 (d, J = 5.0 Hz, 1H), 7.58–7.56 (m, 1H), 7.50–7.33 (m, 3H), 7.21−7.19 (m, 1H), 6.39 (s, 2H), 3.95 (s, 3H); 13C NMR (125 MHz, DMSO-d6) δ 158.6, 157.6, 142.8, 136.8, 136.3, 134.7, 134.6, 130.7, 130.1, 124.2, 124.2, 124.1, 122.8, 120.2, 118.1, 117.9, 117.9, 116.6, 116.4, 109.4, 56.6, 53.9. HRMS (ESI) m/z calcd for C22H15BrF2N2O2 [M − Br]+ 377.1096, found 377.1103.
3-(2,4-Difluorobenzyl)-10-methoxy-6-oxo-6H-indolo[3,2,1-de][1,5]naphthyridin-3-ium bromide6o: yield 58%; yellow solid powder; m.p. 230.6–231.9 °C; 1H NMR (500 MHz, DMSO-d6) δ 9.29 (d, J = 5.0 Hz, 1H), 8.98 (d, J = 5.0 Hz, 1H), 8.64 (d, J = 10.0 Hz, 1H), 8.45 (d, J = 10.0 Hz, 1H), 8.28 (d, J = 2.5 Hz, 1H), 7.60−7.54 (m, 2H), 7.48–7.42 (m, 2H), 7.21−7.18 (m, 1H), 6.38 (s, 2H), 3.98 (s, 3H); 13C NMR (125 MHz, DMSO-d6) δ 158.6, 157.5, 142.5, 136.7, 136.3, 134.6, 134.5, 132.0, 131.9, 131.2, 130.6, 130.0, 124.0, 122.8, 120.1, 118.7, 118.5, 117.9, 109.3, 105.2, 56.6, 53.8. HRMS (ESI) m/z calcd for C22H15BrF2N2O2 [M − Br]+ 377.1096, found 377.1099.
3-(3,4-Dichlorobenzyl)-10-methoxy-6-oxo-6H-indolo[3,2,1-de][1,5]naphthyridin-3-ium bromide6p: yield 46%; orange solid powder; m.p. 223.7–224.5 °C; 1H NMR (500 MHz, DMSO-d6) δ 9.40 (d, J = 5.0 Hz, 1H), 9.02 (d, J = 10.0 Hz, 1H), 8.60 (d, J = 10.0 Hz, 1H), 8.42 (d, J = 10.0 Hz, 1H), 8.30 (d, J = 2.5 Hz, 1H), 7.77 (d, J = 5.0 Hz, 1H), 7.73 (d, J = 10.0 Hz, 1H), 7.59−7.56 (m, 1H), 7.45−7.43 (m, 1H), 7.40 (d, J = 10.0 Hz, 1H), 6.35 (s, 2H), 3.98 (s, 3H); 13C NMR (125 MHz, DMSO-d6) δ 158.7, 157.6, 142.6, 136.7, 136.2, 135.8, 134.7, 134.7, 132.2, 131.6, 130.4, 130.2, 130.0, 128.6, 128.5, 124.1, 122.7, 120.3, 117.8, 109.4, 57.9, 56.6. HRMS (ESI) m/z calcd for C22H15BrCl2N2O2 [M − Br]+ 409.0505, found 409.0504.
3-(2-Bromobenzyl)-10-methoxy-6-oxo-6H-indolo[3,2,1-de][1,5]naphthyridin-3-ium bromide6q: yield 62%; brick yellow solid powder; m.p. 235.5–236.0 °C; 1H NMR (500 MHz, DMSO-d6) δ 9.20 (d, J = 10.0 Hz, 1H), 8.97 (d, J = 5.0 Hz, 1H), 8.47−8.45 (m, 2H), 8.28 (d, J = 2.5 Hz, 1H), 7.81 (d, J = 5.0 Hz, 1H), 7.59 (d, J = 10.0 Hz, 1H), 7.42–7.28 (m, 3H), 6.82–6.81 (m, 1H), 6.34 (s, 2H), 3.96 (s, 3H); 13C NMR (125 MHz, DMSO-d6) δ 158.7, 157.6, 142.6, 136.9, 136.4, 134.7, 134.6, 134.2, 133.6, 131.2, 130.9, 130.2, 129.1, 129.0, 124.1, 122.8, 122.4, 120.2, 117.9, 109.4, 59.6, 56.6. HRMS (ESI) m/z calcd for C22H16Br2N2O2 [M − Br]+ 419.0389, found 419.0355.
3-(4-Bromobenzyl)-10-methoxy-6-oxo-6H-indolo[3,2,1-de][1,5]naphthyridin-3-ium bromide6r: yield 65%; yellow solid powder; m.p. 234.5–235.2 °C; 1H NMR (500 MHz, DMSO-d6) δ 9.39 (d, J = 10.0 Hz, 1H), 9.01 (d, J = 5.0 Hz, 1H), 8.59 (d, J = 10.0 Hz, 1H), 8.44 (d, J = 10.0 Hz, 1H), 8.28 (d, J = 2.5 Hz, 1H), 7.65 (d, J = 5.0 Hz, 2H), 7.59−7.57 (m, 1H), 7.41–7.38 (m, 3H), 6.32 (s, 2H), 3.98 (s, 3H); 13C NMR (125 MHz, DMSO-d6) δ 158.6, 157.5, 142.5, 136.6, 136.2, 134.7, 134.6, 134.4, 132.4, 130.3, 130.2, 130.0, 124.1, 122.7, 122.7, 120.2, 117.9, 109.3, 58.6, 56.6. HRMS (ESI) m/z calcd for C22H16Br2N2O2 [M − Br]+ 419.0389, found 419.0381.
3-(3-Bromobenzyl)-10-methoxy-6-oxo-6H-indolo[3,2,1-de][1,5]naphthyridin-3-ium bromide6s: yield 64%; brick red solid powder; m.p. 238.7–239.1 °C; 1H NMR (500 MHz, DMSO-d6) δ 9.41 (d, J = 10.0 Hz, 1H), 9.01 (d, J = 5.0 Hz, 1H), 8.62 (d, J = 10.0 Hz, 1H), 8.43 (d, J = 10.0 Hz, 1H), 8.29 (d, J = 2.5 Hz, 1H), 7.71 (s, 1H), 7.64−7.62 (m, 1H), 7.58–7.56 (m, 1H), 7.42–7.40 (m, 3H), 6.35 (s, 2H), 3.98 (s, 3H); 13C NMR (125 MHz, DMSO-d6) δ 158.6, 157.6, 142.6, 137.5, 136.6, 136.2, 134.7, 134.6, 132.3, 131.7, 130.7, 130.4, 130.0, 127.0, 124.1, 122.8, 122.7, 120.2, 117.8, 109.3, 58.4, 56.6. HRMS (ESI) m/z calcd for C22H16Br2N2O2 [M − Br]+ 419.0389, found 419.0386.
3-(3-Iodobenzyl)-10-methoxy-6-oxo-6H-indolo[3,2,1-de][1,5]naphthyridin-3-ium bromide6t: yield 42%; red solid powder; m.p. 245.6–246.3 °C; 1H NMR (500 MHz, DMSO-d6) δ 9.38 (d, J = 10.0 Hz, 1H), 8.99 (d, J = 5.0 Hz, 1H), 8.58 (d, J = 10.0 Hz, 1H), 8.44 (d, J = 5.0 Hz, 1H), 8.28 (d, J = 2.5 Hz, 1H), 7.81 (d, J = 10.0 Hz, 2H), 7.60–7.57 (m, 1H), 7.39 (d, J = 10.0 Hz, 1H), 7.23 (d, J = 5.0 Hz, 2H), 6.29 (s, 2H), 3.98 (s, 3H); 13C NMR (125 MHz, DMSO-d6) δ 158.7, 157.6, 142.6, 136.9, 136.4, 134.7, 134.6, 134.2, 133.6, 131.2, 130.9, 130.2, 129.1, 129.0, 124.1, 122.8, 122.4, 120.2, 117.9, 109.4, 60.2, 56.6. HRMS (ESI) m/z calcd for C22H16BrIN2O2 [M − Br]+ 467.0251, found 467.0251.
3-Benzyl-10-methoxy-6-oxo-6H-indolo[3,2,1-de][1,5]naphthyridin-3-ium bromide6u: yield 65%; yellow solid powder; m.p. 224.1–224.5 °C; 1H NMR (500 MHz, DMSO-d6) δ 9.43 (d, J = 5.0 Hz, 1H), 9.02 (d, J = 10.0 Hz, 1H), 8.63 (d, J = 10.0 Hz, 1H), 8.40 (d, J = 10.0 Hz, 1H), 8.28 (d, J = 2.5 Hz, 1H), 7.56−7.53 (m, 1H), 7.44–7.37 (m, 6H), 6.36 (s, 2H), 3.97 (s, 3H); 13C NMR (125 MHz, DMSO-d6) δ 158.6, 157.5, 142.5, 136.5, 136.2, 135.1, 134.6, 134.5, 130.3, 130.1, 129.6, 129.4, 127.9, 124.1, 122.6, 120.2, 117.8, 109.3, 59.3, 56.6. HRMS (ESI) m/z calcd for C22H17BrN2O2 [M − Br]+ 341.1284, found 341.1275.
3-Benzyl-10-methoxy-6-oxo-6H-indolo[3,2,1-de][1,5]naphthyridin-3-ium chloride6v: yield 56%; yellow solid powder; m.p. 222.4–222.9°C; 1H NMR (500 MHz, DMSO-d6) δ 9.42 (d, J = 5.0 Hz, 1H), 9.01 (d, J = 5.0 Hz, 1H), 8.62 (d, J = 10.0 Hz, 1H), 8.44 (d, J = 10.0 Hz, 1H), 8.29(s, 1H), 7.58 (d, J = 10.0 Hz, 1H), 7.44–7.38 (m, 6H), 6.35 (s, 2H), 3.98 (s, 3H); 13C NMR (125 MHz, DMSO-d6) δ 158.6, 157.6, 142.5, 136.5, 136.2, 135.1, 134.6, 134.6, 130.3, 130.1, 129.6, 129.4, 127.9, 124.1, 122.6, 120.2, 117.9, 109.3, 59.3, 56.6. HRMS (ESI) m/z calcd for C22H17ClN2O2 [M − Cl]+ 341.1284, found 341.1274.

3.3. Antibacterial Assay

The MIC values were determined as described by the National Committee for Clinical Laboratory Standards with minor modification [15,24,25,26]. B. cereus (CGMCC 1.1846) was purchased from the China General Microbiological Culture Collection Center. R. solanacearum and P. syringae were provided by the College of Plant Protection, Northwest A&F University [27]. The MIC was defined as the minimum inhibitory concentration, each compound resulting in visible inhibition on bacteria growth (incubation at 37 °C for 12–14 h). Each bacterial suspension was adjusted to a concentration of 1 × 105 CFU/mL. All compounds were thoroughly dried before weighing. Initially, the compounds were dissolved in dimethyl sulfoxide (DMSO) to prepare the stock solutions. The tested compounds (5 and 6a–6v) and reference drugs were then prepared in liquid Luria–Bertani media. The required concentrations were 125, 62.5, 31.25, 15.63, 7.81, 3.91 and 1.95 μg/mL, respectively (DMSO < 0.5%). Triplicate experiments were conducted.

3.4. Calculation of Molecular Physicochemical Properties

Molecular properties, including the octanol–water partition coefficient, the topological polar surface area, the number of hydrogen bond acceptors, the number of hydrogen bond donors, the number of rotatable bonds, and the molecular weight, were calculated using the Molinspiration tool www.molinspiration.com.

3.5. Cell Toxicity Evaluation

The cytotoxicity of highly active compounds 6p and 6t was assessed using the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) assay, as described previously [13,14]. Baby hamster Syrian kidney cells BHK-21 were treated with compounds 6p and 6t at concentrations of 3.91, 7.81 and 15.62 μg/mL. After incubation, 10 μL (5 mg/mL) of MTT in phosphate-buffered saline was added to each well, and the cells were incubated in 5% CO2 at 37 °C for 4 h. The medium was removed. Then, the DMSO (150 µL) was added to each well. The wells were shocked for 15 min in a flat shaker to dissolve purple formazan crystals. Finally, the plate was tested at 540 nm. The untreated group was considered as the control. Triplicate experiments were conducted. The data were analyzed by GraphPad Prism 6.0 (GraphPad Software, San Diego, CA, USA). The formula used for cell viability was (absorbance of compound-treated cells/absorbance of untreated cells) × 100%.

3.6. Germination Rate Bioassay

The seeds of two herbaceous plants, turnip (Raphanus sativus) and wheat (Triticum aestivum L.), were used for the bioassay. The procedure was conducted according to the reported protocol [14]. The plant seeds were washed with running water for 2 h, soaked in 0.3% KMnO4 for 15 min, and flushed until they were colorless. The compounds 6p and 6t, positive control and blank solvent acetone, were added to 12-well plates with filter paper to final concentration of 3.91 μg/mL. After the evaporation of acetone, the plant seeds were sown in the microdishes of 12-well plates and irrigated with sterile deionized water. Triplicate experiments were conducted. The plates were then incubated at 26 °C for 48 h, and the germination rates were calculated according to Equation (1). Germination rates were expressed as means ± the standard deviation (SD) for three replicates.
Germination rate (%) = number of germinated seeds/total number of seeds

4. Conclusions

In this study, twenty-two new quaternarization 10-methoxycanthin-6-one derivatives were designed and synthesized based on our previous work. Their antibacterial activity was evaluated against three bacterial strains including two kinds of agricultural pathogenic bacteria. Four compounds (6f, 6i, 6p and 6t) displayed 8-fold superiority (MIC = 3.91 µg/mL) against R. solanacearum and P. syringae compared to agrochemical streptomycin sulfate. Simultaneously, the structure–activity relationships were summarized, which provided some important guidance for the development of antibacterial agents. The good “drug-like” properties, low cytotoxicity and no inhibition on seed germination of the highly active compounds 6p and 6t further confirmed their potential as bactericides and preservatives, which is of great meaning both to agricultural production and food industry.

Supplementary Materials

The following are available online, Figure S1: The NMR, HRMS and HPLC spectra of compound 5, Figures S1–S23: The NMR, HRMS and HPLC spectra of compound 6a–6v.

Author Contributions

N.L. conceived and conducted this work; J.-K.D. reelucidated the compound structures via their new spectroscopic data and prepared the discussion part of the manuscript; D.L. conducted the synthesis work; J.-R.W. and J.-Y.W. designed and wrote the paper.

Funding

This work was funded by the National Natural Science Foundation of China (Grant No. 81773603).

Acknowledgments

We acknowledge the Life Science Large Research Core Services in the university, and also acknowledge Hongli Zhang for providing the help in the NMR analysis.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Laxminarayan, R.; Duse, A.; Wattal, C.; Zaidi, A.K.M.; Wertheim, H.F.L.; Sumpradit, N.; Vlieghe, E.; Hara, G.L.; Gould, I.M.; Goossens, H.; et al. Antibiotic resistance-the need for global solutions. Lancet Infect. Dis. 2013, 13, 1057–1098. [Google Scholar] [CrossRef]
  2. Economou, V.; Gousia, P. Agriculture and food animals as a source of antimicrobial-resistant bacteria. Infect. Drug Resist. 2015, 8, 49–61. [Google Scholar] [CrossRef] [Green Version]
  3. Pal, C.; Bengtsson-Palme, J.; Kristiansson, E.; Larsson, D.G.J. The structure and diversity of human, animal and environmental resistomes. Microbiome 2016, 4, 54. [Google Scholar] [CrossRef]
  4. Diao, M.; Qi, D.; Xu, M.; Lu, Z.; Lv, F.; Bie, X.; Zhang, C.; Zhao, H. Antibacterial activity and mechanism of monolauroylgalactosylglycerol against Bacillus cereus. Food Control 2018, 85, 339–344. [Google Scholar] [CrossRef]
  5. Miao, J.X.; Guo, H.X.; Chen, F.L.; Zhao, L.C.; He, L.P.; Ou, Y.W.; Huang, M.M.; Zhang, Y.; Guo, B.Y.; Cao, Y.; et al. Antibacterial effects of a cell-penetrating peptide isolated from Kefir. J. Agric. Food Chem. 2016, 64, 3234–3242. [Google Scholar] [CrossRef] [PubMed]
  6. Pisoschi, A.M.; Pop, A.; Georgescu, C.; Turcus, V.; Olah, N.K.; Mathe, E. An overview of natural antimicrobials role in food. Eur. J. Med. Chem. 2018, 143, 922–935. [Google Scholar] [CrossRef]
  7. Salanoubat, M.; Genin, S.; Artiguenave, F.; Gouzy, J.; Mangenot, S.; Arlat, M.; Billault, A.; Brottier, P.; Camus, J.; Cattolico, L. Genome sequence of the plant pathogen Ralstonia solanacearum. Nature 2002, 415, 497–502. [Google Scholar] [CrossRef] [PubMed]
  8. Zhao, X.M.; Xi, X.; Hu, Z.; Wu, W.J.; Zhang, J.W. Exploration of novel botanical insecticide leads: Synthesis and insecticidal activity of beta-dihydroagarofuran derivatives. J. Agric. Food Chem. 2016, 64, 1503–1508. [Google Scholar] [CrossRef] [PubMed]
  9. Zhang, B.C.; Sun, Z.Q.; Lv, M.; Xu, H. Semisynthesis of matrinic acid/alcohol/ester derivatives, their pesticidal activities, and investigation of mechanisms of action against Tetranychus cinnabarinus. J. Agric. Food Chem. 2018, 66, 12898–12910. [Google Scholar] [CrossRef] [PubMed]
  10. Dai, J.K.; Li, N.; Wang, J.R.; Schneider, U. Fruitful decades for canthin-6-ones from 1952 to 2015: Biosynthesis, chemistry, and biological activities. Molecules 2016, 21, 493. [Google Scholar] [CrossRef]
  11. Dai, J.K.; Dan, W.J.; Schneider, U.; Wang, J.R. β-Carboline alkaloid monomers and dimers: Occurrence, structural diversity, and biological activities. Eur. J. Med. Chem. 2018, 157, 622–656. [Google Scholar] [CrossRef]
  12. Dai, J.K.; Dan, W.J.; Li, N.; Du, H.T.; Zhang, J.W.; Wang, J.R. Synthesis, in vitro antibacterial activities of a series of 3-N-substituted canthin-6-ones. Bioorg. Med. Chem. Lett. 2016, 26, 580–583. [Google Scholar] [CrossRef]
  13. Dai, J.K.; Dan, W.J.; Ren, S.Y.; Shang, C.G.; Wang, J.R. Design, synthesis and biological evaluations of quaternization harman analogues as potential antibacterial agents. Eur. J. Med. Chem. 2018, 160, 23–36. [Google Scholar] [CrossRef]
  14. Dai, J.K.; Dan, W.J.; Zhang, Y.Y.; He, M.F.; Wang, J.R. Design and synthesis of C10 modified and ring-truncated canthin-6-one analogues as effective membrane-active antibacterial agents. Bioorg. Med. Chem. Lett. 2018, 28, 3123–3128. [Google Scholar] [CrossRef]
  15. Zhao, F.; Dai, J.K.; Li, D.; Wang, S.J.; Wang, J.R. Synthesis and evaluation of ester derivatives of 10-hydroxycanthin-6-one as potential antimicrobial agents. Molecules 2016, 21, 390. [Google Scholar] [CrossRef]
  16. Dai, J.K.; Dan, W.J.; Li, N.; Wang, J.R. Computer-aided drug discovery: Novel 3,9-disubstituted eudistomin U derivatives as potent antibacterial agents. Eur. J. Med. Chem. 2018, 157, 333–338. [Google Scholar] [CrossRef]
  17. Dai, J.K.; Dan, W.J.; Li, N.; Wang, R.X.; Zhang, Y.; Li, N.N.; Wang, R.Z.; Wang, J.R. Synthesis and antibacterial activity of C2 or C5 modified and D ring rejiggered canthin-6-one analogues. Food Chem. 2018, 253, 211–220. [Google Scholar] [CrossRef]
  18. Li, D.; Zhang, S.; Song, Z.; Li, W.; Zhu, F.; Zhang, J.; Li, S. Synthesis and bio-inspired optimization of drimenal: Discovery of chiral drimane fused oxazinones as promising antifungal and antibacterial candidates. Eur. J. Med. Chem. 2018, 143, 558–567. [Google Scholar] [CrossRef]
  19. Lipinski, C.A.; Lombardo, F.; Dominy, B.W.; Feeney, P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 1997, 23, 3–25. [Google Scholar] [CrossRef]
  20. Clarke, E.D.; Delaney, J.S. Physical and molecular properties of agrochemicals: An analysis of screen inputs, hits, leads, and products. Chimia 2003, 57, 731–734. [Google Scholar] [CrossRef]
  21. Hou, W.; Zhang, G.J.; Luo, Z.; Li, D.; Quan, H.Q.; Ruan, B.H.; Su, L.; Xu, H.T. Identification of a diverse synthetic abietane diterpenoid library and insight into the structure–activity relationships for antibacterial activity. Bioorg. Med. Chem. Lett. 2017, 27, 5382–5386. [Google Scholar] [CrossRef]
  22. Xu, Q.B.; Chen, X.F.; Feng, J.; Miao, J.F.; Liu, J.; Liu, F.T.; Niu, B.X.; Cai, J.Y.; Huang, Y.; Zhang, N.; et al. Design, synthesis and biological evaluation of hybrids of β-carboline and salicylic acid as potential anticancer and apoptosis inducing agents. Sci. Rep. 2016, 6, 36238. [Google Scholar] [CrossRef]
  23. Elazouni, I.; Abdel-Aziz, S.; Rabea, A. Microbial efficacy as biological agents for potato enrichment as well as bio-controls against wilt disease caused by Ralstonia solanacearum. World J. Microbiol. Biotechnol. 2019, 35, 30. [Google Scholar] [CrossRef]
  24. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing; 11th Informational Supplement; M100-S11; National Committee for Clinical Laboratory Standards: Wayne, PA, USA, 2001; Volume 21. [Google Scholar]
  25. Feng, L.; Maddox, M.M.; Alam, M.Z.; Tsutsumi, L.S.; Narula, G.; Bruhn, D.F.; Wu, X.; Sandhaus, S.; Lee, R.B.; Simmons, C.J.; et al. Synthesis, structure−activity relationship studies, and antibacterial evaluation of 4-chromanones and chalcones, as well as olympicin A and derivatives. J. Med. Chem. 2014, 57, 8398–8420. [Google Scholar] [CrossRef]
  26. Su, M.; Xia, D.L.; Teng, P.; Nimmagadda, A.; Zhang, C.; Odom, T.; Cao, A.N.; Hu, Y.; Cai, J.F. Membrane-active hydantoin derivatives as antibiotic agents. J. Med. Chem. 2017, 60, 8456–8465. [Google Scholar] [CrossRef]
  27. Dan, W.J.; Geng, H.L.; Qiao, J.W.; Guo, R.; Wei, S.P.; Li, L.B.; Wu, W.J.; Zhang, J.W. Efficient synthesis and sntibacterial evaluation of (±)-Yanglingmycin and its analogues. Molecules 2016, 21, 96. [Google Scholar] [CrossRef]
Sample Availability: Samples of all the compounds in this paper are available from the authors.
Molecules 24 01553 g001 550
Figure 1. Design of the quaternized 10-methoxycanthin-6-one analogues.
Figure 1. Design of the quaternized 10-methoxycanthin-6-one analogues.
Molecules 24 01553 g001
Molecules 24 01553 sch001 550
Scheme 1. Synthetic route and chemical structures of compounds 5 and 6a–6v. Reagents and conditions: (a) i: benzaldehyde, MeOH, r.t.; ii: NaBH4, r.t., 98%; (b) α-ketoglutaric acid, p-TSA, dry toluene:dioxane = 3:2, DST, reflux, 83%; (c) HCOONH4, 5% Pd/C, MeOH:toluene = 1:1, heated, 75%; (d) 5% Pd/C, xylene, reflux, 90%; (e) CH3CN, reflux, r.t., 42–72%.
Scheme 1. Synthetic route and chemical structures of compounds 5 and 6a–6v. Reagents and conditions: (a) i: benzaldehyde, MeOH, r.t.; ii: NaBH4, r.t., 98%; (b) α-ketoglutaric acid, p-TSA, dry toluene:dioxane = 3:2, DST, reflux, 83%; (c) HCOONH4, 5% Pd/C, MeOH:toluene = 1:1, heated, 75%; (d) 5% Pd/C, xylene, reflux, 90%; (e) CH3CN, reflux, r.t., 42–72%.
Molecules 24 01553 sch001
Table
Table 1. Antibacterial activity of compounds 5 and 6a–6v against three bacteria (MIC, µg/mL).
Table 1. Antibacterial activity of compounds 5 and 6a–6v against three bacteria (MIC, µg/mL).
No.RXB. cereusR. solanacearumP. syringae
6a-CH2Ph(o-F)Br15.6315.6315.63
6b-CH2Ph(p-F)Br15.6315.6315.63
6c-CH2Ph(m-F)Br31.257.8115.63
6d-CH2Ph(m-CN)Cl62.5015.6315.63
6e-CH2Ph(o-Cl)Cl15.633.917.81
6f-CH2Ph(m-Cl)Cl15.633.913.91
6g-CH2Ph(o-Me)Br15.637.817.81
6h-CH2Ph(p-Me)Br15.637.813.91
6i-CH2Ph(m-Me)Br15.633.913.91
6j-CH2Ph(m-OMe)Cl15.6315.637.81
6k-CH2Ph(o-CF3)Br15.633.917.81
6l-CH2Ph(p-CF3)Br15.633.917.81
6m-CH2Ph(m-CF3)Br15.633.9115.63
6n-CH2Ph(2,5-difluoro)Br31.257.8115.63
6o-CH2Ph(2,4-difluoro)Br15.6315.637.81
6p-CH2Ph(3,4-dichloro)Br7.813.913.91
6q-CH2Ph(o-Br)Br7.817.8115.63
6r-CH2Ph(p-Br)Br7.817.817.81
6s-CH2Ph(m-Br)Br15.637.817.81
6t-CH2Ph(m-I)Br7.813.913.91
6u-CH2PhBr15.6315.6315.63
6v-CH2PhCl15.6315.6315.63
5--3.9115.637.81
F.S. a--3.911.9515.63
A.S. a--3.917.810.98
S.S. a--15.6331.2531.25
a Fosfomycin sodium; Ampicillin sodium; Streptomycin sulfate.
Table
Table 2. Structure–activity relationships (SARs) against R. solanacearum and P. syringae.
Table 2. Structure–activity relationships (SARs) against R. solanacearum and P. syringae.
Molecules 24 01553 i001
LocationBacteria StrainsSARs
Ortho-positionR. solanacearumF < Br = Me < Cl = CF3
P. syringaeF = Br < Cl = Me = CF3
Meta-positionR. solanacearumCN = OMe < F = Br < Cl = I = Me = CF3
P. syringaeF = CN = CF3 < OMe = Br < Cl = I = Me
Para-positionR. solanacearumF < Br = Me < CF3
P. syringaeF < Br = CF3 < Me
Table
Table 3. Calculated molecular properties of some potential compounds.
Table 3. Calculated molecular properties of some potential compounds.
No.LogP aTPSA bnON cnONNH dNrotb eMW f
52.7243.61401250.2
6p1.1834.6403410.3
6t0.9834.6403467.3
a LogP = octanol–water partition coefficient, b TPSA = topologic polar surface area, c nON = number of hydrogen bond acceptors, d nONNH = number of hydrogen bond donors, e nrotb = number of rotatable bonds, f MW = molecular weight.
Table
Table 4. The cell viability of highly active compounds 6p and 6t.
Table 4. The cell viability of highly active compounds 6p and 6t.
No.Cell Viability (%)
3.91 μg/mL7.81 μg/mL15.62 μg/mL
6p99.7 ± 2.998.2 ± 2.796.3 ± 4.4
6t98.7 ± 2.298.2 ± 4.196.1 ± 3.8
Table
Table 5. The germination rate on turnip (Raphanus sativus) and wheat (Triticum aestivum L.) of compounds 6p and 6t (3.91 μg/mL).
Table 5. The germination rate on turnip (Raphanus sativus) and wheat (Triticum aestivum L.) of compounds 6p and 6t (3.91 μg/mL).
No.Turnip (%)Wheat (%)
6p94 ± 0.3393 ± 0.89
6t91 ± 0.8796 ± 0.55
GP76 ± 0.3372 ± 0.83
CK93 ± 0.5395 ± 0.57

Share and Cite

MDPI and ACS Style

Li, N.; Liu, D.; Dai, J.-K.; Wang, J.-Y.; Wang, J.-R. Synthesis and In Vitro Antibacterial Activity of Quaternized 10-Methoxycanthin-6-one Derivatives. Molecules 2019, 24, 1553. https://doi.org/10.3390/molecules24081553

AMA Style

Li N, Liu D, Dai J-K, Wang J-Y, Wang J-R. Synthesis and In Vitro Antibacterial Activity of Quaternized 10-Methoxycanthin-6-one Derivatives. Molecules. 2019; 24(8):1553. https://doi.org/10.3390/molecules24081553

Chicago/Turabian Style

Li, Na, Dan Liu, Jiang-Kun Dai, Jin-Yi Wang, and Jun-Ru Wang. 2019. "Synthesis and In Vitro Antibacterial Activity of Quaternized 10-Methoxycanthin-6-one Derivatives" Molecules 24, no. 8: 1553. https://doi.org/10.3390/molecules24081553

APA Style

Li, N., Liu, D., Dai, J. -K., Wang, J. -Y., & Wang, J. -R. (2019). Synthesis and In Vitro Antibacterial Activity of Quaternized 10-Methoxycanthin-6-one Derivatives. Molecules, 24(8), 1553. https://doi.org/10.3390/molecules24081553

Article Metrics

Back to TopTop